Interestingly, a positive correlation between increased numbers of CD8+ T cells and Tregs in the TME has been observed in multiple patients with ovarian cancer, but this immune profile has not influenced patients’ overall survival [280]. This evidence concerns the gene CD8A and ovarian carcinoma.